Literature DB >> 18854516

Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis.

M E Perry, M M Chee, W R Ferrell, J C Lockhart, R D Sturrock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18854516     DOI： 10.1136/ard.2007.082917

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  11 in total

Review 1.  Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy.

Authors:  Elena Bartoloni; Alessia Alunno; Onelia Bistoni; Roberto Gerli
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

2.  Angiotensin-Receptor Blockade Improves Inflammation and Endothelial Dysfunction in Ankylosing Spondylitis: ARB-AS Study.

Authors:  Nidhi Garg; Pawan Krishan; Ashit Syngle
Journal:  Int J Angiol       Date:  2021-01-29

3.  Rheumatoid arthritis patients with active disease and no history of cardiac pathology have higher brain natriuretic peptide (BNP) levels than patients with inactive disease or healthy control subjects.

Authors:  D J Armstrong; P V Gardiner; M J O'Kane
Journal:  Ulster Med J       Date:  2010-05

Review 4.  Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents.

Authors:  Federico Carbone; Aldo Bonaventura; Luca Liberale; Sabrina Paolino; Francesco Torre; Franco Dallegri; Fabrizio Montecucco; Maurizio Cutolo
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 5.  Angiotensin II in inflammation, immunity and rheumatoid arthritis.

Authors:  Y Chang; W Wei
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

6.  Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis.

Authors:  Di Wang; Shanshan Hu; Jie Zhu; Jun Yuan; Jingjing Wu; Aiwu Zhou; Yujing Wu; Wendi Zhao; Qiong Huang; Yan Chang; Qingtong Wang; Wuyi Sun; Wei Wei
Journal:  J Cell Mol Med       Date:  2013-09-23       Impact factor: 5.310

7.  Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium.

Authors:  Riccardo Terenzi; Mirko Manetti; Irene Rosa; Eloisa Romano; Felice Galluccio; Serena Guiducci; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

8.  A comparative study on the anti-inflammatory effect of angiotensin-receptor blockers & statins on rheumatoid arthritis disease activity.

Authors:  Tarek Mohamed Mostafa; Sahar Kamal Hegazy; Emad M Elshebini; Dalia S Saif; Ahmed H Elabd
Journal:  Indian J Med Res       Date:  2020-10       Impact factor: 2.375

9.  Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.

Authors:  Ting-Tse Lin; Cho-Kai Wu; Min-Tsun Liao; Yao-Hsu Yang; Pau-Chung Chen; Dong-Feng Yeih; Lian-Yu Lin
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

Review 10.  The Tissue Renin-Angiotensin System and Its Role in the Pathogenesis of Major Human Diseases: Quo Vadis?

Authors:  Babak Saravi; Zhen Li; Corinna N Lang; Bonaventura Schmid; Frauke K Lang; Sibylle Grad; Mauro Alini; Robert Geoffrey Richards; Hagen Schmal; Norbert Südkamp; Gernot M Lang
Journal:  Cells       Date:  2021-03-15       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.